| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.885 | 0.002 | 0.885 | 5 Hydroxytryptamine release stimulant | 0.885 0.002 CID_3651 | ||
| 0.754 | 0.001 | 0.754 | 5 Hydroxytryptamine uptake stimulant | 0.745 0.001 CID_3651 | ||
| 0.682 | 0.004 | 0.682 | Psychostimulant | 0.661 0.005 CID_3651 | ||
| 0.653 | 0.003 | 0.795 | Tyrosine 3 hydroxylase inhibitor | 0.795 0.002 CID_3651 | CID_3651 | |
| 0.614 | 0.009 | 0.637 | 5 Hydroxytryptamine release inhibitor | 0.637 0.007 CID_3651 | CID_3651 | |
| 0.597 | 0.004 | 0.597 | 5 Hydroxytryptamine 1F antagonist | 0.376 0.005 CID_3651 | ||
| 0.593 | 0.004 | 0.593 | 5 Hydroxytryptamine agonist | 0.297 0.008 CID_3651 | ||
| 0.561 | 0.009 | 0.656 | Superoxide dismutase inhibitor | 0.656 0.005 CID_3651 | CID_3651 | |
| 0.522 | 0.03 | 0.677 | Aldehyde oxidase inhibitor | 0.677 0.01 CID_3651 | CID_3651 | |
| 0.473 | 0.012 | 0.626 | Peroxidase inhibitor | 0.626 0.004 CID_3651 | CID_3651 | |
| 0.431 | 0.012 | 0.431 | Growth hormone agonist | 0.411 0.014 CID_3651 | ||
| 0.415 | 0.017 | 0.415 | Interleukin agonist | 0.403 0.018 CID_3651 | ||
| 0.385 | 0.003 | 0.553 | Phenylalanine 4-hydroxylase inhibitor | 0.553 0.002 CID_3651 | CID_3651 | |
| 0.399 | 0.028 | 0.406 | Interleukin 2 agonist | 0.406 0.025 CID_3651 | CID_3651 | |
| 0.393 | 0.023 | 0.404 | Insulysin inhibitor | 0.404 0.021 CID_3651 | CID_3651 | |
| 0.408 | 0.038 | 0.445 | Spasmolytic | 0.445 0.032 CID_3651 | CID_3651 | |
| 0.419 | 0.053 | 0.449 | GABA C receptor rho-3 antagonist | 0.449 0.042 CID_3651 | CID_3651 | |
| 0.375 | 0.01 | 0.375 | Alpha-N-acetylglucosaminidase inhibitor | 0.335 0.013 CID_3651 | ||
| 0.387 | 0.04 | 0.395 | Vasodilator, coronary | 0.395 0.037 CID_3651 | CID_3651 | |
| 0.424 | 0.081 | 0.424 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.299 0.214 CID_3651 | ||
| 0.408 | 0.072 | 0.46 | Histamine release inhibitor | 0.46 0.045 CID_3651 | CID_3651 | |
| 0.408 | 0.076 | 0.475 | Calcium channel L-type activator | 0.475 0.038 CID_3651 | CID_3651 | |
| 0.354 | 0.023 | 0.379 | Anesthetic general | 0.379 0.019 CID_3651 | CID_3651 | |
| 0.324 | 0.005 | 0.324 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.286 0.007 CID_3651 | ||
| 0.387 | 0.071 | 0.387 | Antiobesity | 0.286 0.126 CID_3651 | ||
| 0.314 | 0.004 | 0.314 | 5 Hydroxytryptamine 2C agonist | 0.164 0.005 CID_3651 | ||
| 0.413 | 0.104 | 0.481 | Caspase 9 stimulant | 0.481 0.068 CID_3651 | CID_3651 | |
| 0.315 | 0.008 | 0.315 | GABA C receptor agonist | 0.302 0.009 CID_3651 | ||
| 0.307 | 0.007 | 0.307 | Ferrochelatase inhibitor | 0.201 0.022 CID_3651 | ||
| 0.305 | 0.006 | 0.428 | Histidine decarboxylase inhibitor | 0.428 0.004 CID_3651 | CID_3651 | |
| 0.366 | 0.072 | 0.489 | Transcription factor NF kappa B inhibitor | 0.489 0.046 CID_3651 | CID_3651 | |
| 0.302 | 0.008 | 0.302 | Aminopeptidase B inhibitor | 0.301 0.008 CID_3651 | ||
| 0.369 | 0.077 | 0.369 | Calpain 2 inhibitor | 0.307 0.11 CID_3651 | ||
| 0.297 | 0.01 | 0.297 | Cathepsin H inhibitor | 0.245 0.014 CID_3651 | ||
| 0.35 | 0.064 | 0.445 | Cholesterol antagonist | 0.445 0.041 CID_3651 | CID_3651 | |
| 0.31 | 0.027 | 0.31 | Gastrin inhibitor | 0.264 0.064 CID_3651 | ||
| 0.323 | 0.041 | 0.352 | Angiogenesis stimulant | 0.352 0.032 CID_3651 | CID_3651 | |
| 0.28 | 0.003 | 0.28 | 5 Hydroxytryptamine 2A agonist | 0.263 0.003 CID_3651 | ||
| 0.282 | 0.007 | 0.282 | 5 Hydroxytryptamine 3E antagonist | 0.227 0.03 CID_3651 | ||
| 0.302 | 0.029 | 0.302 | Calpain inhibitor | 0.284 0.039 CID_3651 | ||
| 0.337 | 0.068 | 0.378 | Immunostimulant | 0.378 0.056 CID_3651 | CID_3651 | |
| 0.336 | 0.07 | 0.364 | Antithrombotic | 0.364 0.06 CID_3651 | CID_3651 | |
| 0.304 | 0.038 | 0.304 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.23 0.071 CID_3651 | ||
| 0.342 | 0.077 | 0.352 | Vasodilator, peripheral | 0.352 0.073 CID_3651 | CID_3651 | |
| 0.28 | 0.017 | 0.305 | Nitric-oxide synthase stimulant | 0.305 0.01 CID_3651 | CID_3651 | |
| 0.283 | 0.028 | 0.283 | Neuropeptide Y2 antagonist | 0.281 0.03 CID_3651 | ||
| 0.259 | 0.004 | 0.259 | Aminopeptidase I inhibitor | 0.248 0.004 CID_3651 | ||
| 0.26 | 0.019 | 0.293 | Neurotensin receptor agonist | 0.293 0.015 CID_3651 | CID_3651 | |
| 0.315 | 0.077 | 0.315 | Calcium channel activator | 0.299 0.093 CID_3651 | ||
| 0.23 | 0.004 | 0.314 | DOPA decarboxylase inhibitor | 0.314 0.002 CID_3651 | CID_3651 | |
| 0.288 | 0.063 | 0.319 | Transcription factor STAT inhibitor | 0.319 0.046 CID_3651 | CID_3651 | |
| 0.229 | 0.006 | 0.229 | Nitric-oxide synthase inhibitor | 0.178 0.014 CID_3651 | ||
| 0.323 | 0.101 | 0.344 | Immunosuppressant | 0.344 0.09 CID_3651 | CID_3651 | |
| 0.253 | 0.033 | 0.273 | Insulin sensitizer | 0.273 0.023 CID_3651 | CID_3651 | |
| 0.247 | 0.027 | 0.247 | Thiol protease inhibitor | 0.208 0.037 CID_3651 | ||
| 0.221 | 0.005 | 0.221 | CYP2A6 inhibitor | 0.152 0.016 CID_3651 | ||
| 0.271 | 0.055 | 0.301 | DNA synthesis inhibitor | 0.301 0.043 CID_3651 | CID_3651 | |
| 0.242 | 0.027 | 0.344 | Phospholipase C inhibitor | 0.344 0.015 CID_3651 | CID_3651 | |
| 0.226 | 0.011 | 0.226 | Catalase inhibitor | 0.222 0.012 CID_3651 | ||
| 0.268 | 0.055 | 0.351 | Interleukin antagonist | 0.351 0.039 CID_3651 | CID_3651 | |
| 0.214 | 0.006 | 0.306 | Glutamate decarboxylase inhibitor | 0.306 0.004 CID_3651 | CID_3651 | |
| 0.268 | 0.063 | 0.365 | Antiamyloidogenic | 0.365 0.036 CID_3651 | CID_3651 | |
| 0.271 | 0.069 | 0.3 | Transcription factor STAT3 inhibitor | 0.3 0.053 CID_3651 | CID_3651 | |
| 0.243 | 0.042 | 0.296 | Neurotrophic factor enhancer | 0.296 0.019 CID_3651 | CID_3651 | |
| 0.21 | 0.01 | 0.238 | Adenylate cyclase stimulant | 0.238 0.005 CID_3651 | CID_3651 | |
| 0.208 | 0.008 | 0.243 | Prolactin inhibitor | 0.243 0.005 CID_3651 | CID_3651 | |
| 0.203 | 0.004 | 0.203 | 5 Hydroxytryptamine 2 agonist | 0.129 0.006 CID_3651 | ||
| 0.206 | 0.007 | 0.206 | Argininosuccinate synthase inhibitor | 0.184 0.009 CID_3651 | ||
| 0.261 | 0.063 | 0.261 | 5 Hydroxytryptamine 1E antagonist | 0.252 0.072 CID_3651 | ||
| 0.211 | 0.015 | 0.211 | Falcipain 3 inhibitor | 0.198 0.018 CID_3651 | ||
| 0.247 | 0.053 | 0.276 | Peptidyltransferase inhibitor | 0.276 0.035 CID_3651 | CID_3651 | |
| 0.199 | 0.013 | 0.199 | GABA C receptor antagonist | 0.194 0.014 CID_3651 | ||
| 0.195 | 0.012 | 0.241 | Opioid delta receptor antagonist | 0.241 0.006 CID_3651 | CID_3651 | |
| 0.194 | 0.014 | 0.194 | Sphingosine 1-phosphate receptor 5 antagonist | 0.192 0.015 CID_3651 | ||
| 0.211 | 0.031 | 0.211 | Nav1.2 sodium channel blocker | 0.163 0.05 CID_3651 | ||
| 0.194 | 0.015 | 0.247 | Opioid antagonist | 0.247 0.008 CID_3651 | CID_3651 | |
| 0.19 | 0.012 | 0.313 | Creatine kinase inhibitor | 0.313 0.004 CID_3651 | CID_3651 | |
| 0.215 | 0.038 | 0.23 | Succinate dehydrogenase inhibitor | 0.23 0.03 CID_3651 | CID_3651 | |
| 0.204 | 0.029 | 0.204 | Histone deacetylase SIRT1 inhibitor | 0.192 0.033 CID_3651 | ||
| 0.184 | 0.011 | 0.184 | Glutamate dehydrogenase inhibitor | 0.181 0.012 CID_3651 | ||
| 0.217 | 0.044 | 0.22 | Thrombolytic | 0.22 0.043 CID_3651 | CID_3651 | |
| 0.189 | 0.017 | 0.189 | Adenylate kinase inhibitor | 0.168 0.021 CID_3651 | ||
| 0.204 | 0.031 | 0.204 | Anesthetic local | 0.169 0.041 CID_3651 | ||
| 0.197 | 0.025 | 0.319 | Cystathionine beta-synthase inhibitor | 0.319 0.008 CID_3651 | CID_3651 | |
| 0.18 | 0.009 | 0.18 | Somatostatin 1 agonist | 0.178 0.009 CID_3651 | ||
| 0.233 | 0.062 | 0.249 | RNA-directed DNA polymerase inhibitor | 0.249 0.05 CID_3651 | CID_3651 | |
| 0.176 | 0.006 | 0.176 | Protein kinase C iota inhibitor | 0.113 0.015 CID_3651 | ||
| 0.186 | 0.019 | 0.281 | Carbonic anhydrase III inhibitor | 0.281 0.006 CID_3651 | CID_3651 | |
| 0.179 | 0.012 | 0.179 | GABA C receptor rho-1 antagonist | 0.162 0.017 CID_3651 | ||
| 0.205 | 0.04 | 0.205 | Acetylcholine M1 receptor antagonist | 0.201 0.042 CID_3651 | ||
| 0.188 | 0.024 | 0.206 | Cyclooxygenase 3 inhibitor | 0.206 0.017 CID_3651 | CID_3651 | |
| 0.174 | 0.012 | 0.174 | Inducible nitric-oxide synthase inhibitor | 0.135 0.02 CID_3651 | ||
| 0.178 | 0.016 | 0.178 | Sphingosine 1-phosphate receptor 2 antagonist | 0.178 0.016 CID_3651 | ||
| 0.191 | 0.031 | 0.259 | MAO A inhibitor | 0.259 0.02 CID_3651 | CID_3651 | |
| 0.176 | 0.016 | 0.176 | Sphingosine 1-phosphate receptor 4 antagonist | 0.16 0.025 CID_3651 | ||
| 0.207 | 0.048 | 0.207 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.164 0.068 CID_3651 | ||
| 0.182 | 0.023 | 0.185 | Nav1.4 sodium channel blocker | 0.185 0.023 CID_3651 | CID_3651 | |
| 0.206 | 0.048 | 0.206 | 3C-like protease (Human coronavirus) inhibitor | 0.158 0.088 CID_3651 | ||
| 0.176 | 0.018 | 0.176 | Cathepsin G inhibitor | 0.169 0.019 CID_3651 | ||
| 0.186 | 0.03 | 0.186 | Proteasome inhibitor | 0.181 0.032 CID_3651 | ||
| 0.175 | 0.021 | 0.205 | Mucolytic | 0.205 0.012 CID_3651 | CID_3651 | |
| 0.168 | 0.014 | 0.218 | Opioid mu receptor antagonist | 0.218 0.007 CID_3651 | CID_3651 | |
| 0.159 | 0.006 | 0.201 | GABA aminotransferase inhibitor | 0.201 0.004 CID_3651 | CID_3651 | |
| 0.174 | 0.021 | 0.187 | Interleukin 8 antagonist | 0.187 0.016 CID_3651 | CID_3651 | |
| 0.175 | 0.023 | 0.249 | Carbonic anhydrase XV inhibitor | 0.249 0.012 CID_3651 | CID_3651 | |
| 0.173 | 0.022 | 0.196 | Vanilloid 1 agonist | 0.196 0.013 CID_3651 | CID_3651 | |
| 0.153 | 0.003 | 0.153 | 5 Hydroxytryptamine 2B agonist | 0.088 0.004 CID_3651 | ||
| 0.179 | 0.031 | 0.179 | 5 Hydroxytryptamine 2B antagonist | 0.128 0.053 CID_3651 | ||
| 0.186 | 0.039 | 0.187 | Hemostatic | 0.187 0.038 CID_3651 | CID_3651 | |
| 0.19 | 0.044 | 0.245 | MAO inhibitor | 0.245 0.029 CID_3651 | CID_3651 | |
| 0.166 | 0.021 | 0.18 | Heat shock protein 70 antagonist | 0.18 0.012 CID_3651 | CID_3651 | |
| 0.179 | 0.034 | 0.224 | Toll-Like receptor 2 antagonist | 0.224 0.015 CID_3651 | CID_3651 | |
| 0.156 | 0.012 | 0.156 | Histamine N-methyltransferase inhibitor | 0.148 0.015 CID_3651 | ||
| 0.176 | 0.033 | 0.179 | Neuropeptide Y1 antagonist | 0.179 0.031 CID_3651 | CID_3651 | |
| 0.166 | 0.023 | 0.169 | Photosensitizer | 0.169 0.022 CID_3651 | CID_3651 | |
| 0.161 | 0.018 | 0.213 | Porphobilinogen synthase inhibitor | 0.213 0.011 CID_3651 | CID_3651 | |
| 0.173 | 0.033 | 0.203 | Adenylate cyclase inhibitor | 0.203 0.025 CID_3651 | CID_3651 | |
| 0.157 | 0.019 | 0.165 | Transcription factor STAT6 inhibitor | 0.165 0.015 CID_3651 | CID_3651 | |
| 0.142 | 0.007 | 0.142 | Granulocyte macrophage colony stimulating factor agonist | 0.138 0.008 CID_3651 | ||
| 0.142 | 0.007 | 0.142 | Protease 3C (Human rhinovirus) inhibitor | 0.113 0.011 CID_3651 | ||
| 0.148 | 0.015 | 0.22 | Adrenaline agonist | 0.22 0.005 CID_3651 | CID_3651 | |
| 0.158 | 0.026 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.158 0.027 CID_3651 | ||
| 0.158 | 0.026 | 0.158 | Protease inhibitor | 0.136 0.037 CID_3651 | ||
| 0.182 | 0.049 | 0.238 | Interferon gamma antagonist | 0.238 0.031 CID_3651 | CID_3651 | |
| 0.141 | 0.012 | 0.141 | Carbonic anhydrase stimulant | 0.108 0.017 CID_3651 | ||
| 0.18 | 0.051 | 0.3 | Melanin inhibitor | 0.3 0.022 CID_3651 | CID_3651 | |
| 0.144 | 0.016 | 0.187 | Analgesic, opioid | 0.187 0.01 CID_3651 | CID_3651 | |
| 0.14 | 0.012 | 0.14 | Carbamoyl phosphate synthetase inhibitor | 0.132 0.013 CID_3651 | ||
| 0.166 | 0.038 | 0.166 | Nav1.6 sodium channel blocker | 0.138 0.07 CID_3651 | ||
| 0.137 | 0.011 | 0.137 | Adrenaline uptake inhibitor | 0.081 0.026 CID_3651 | ||
| 0.173 | 0.048 | 0.173 | GABA C receptor rho-2 antagonist | 0.166 0.055 CID_3651 | ||
| 0.14 | 0.014 | 0.149 | Ornithine decarboxylase inhibitor | 0.149 0.011 CID_3651 | CID_3651 | |
| 0.13 | 0.005 | 0.13 | Glutamate (mGluR6) antagonist | 0.112 0.007 CID_3651 | ||
| 0.14 | 0.016 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | 0.135 0.018 CID_3651 | ||
| 0.144 | 0.021 | 0.144 | Factor V inhibitor | 0.123 0.036 CID_3651 | ||
| 0.162 | 0.04 | 0.162 | Cell adhesion inhibitor | 0.134 0.056 CID_3651 | ||
| 0.155 | 0.033 | 0.199 | Expectorant | 0.199 0.02 CID_3651 | CID_3651 | |
| 0.134 | 0.012 | 0.134 | Sphingosine 1-phosphate receptor 4 agonist | 0.125 0.015 CID_3651 | ||
| 0.196 | 0.075 | 0.207 | Non-steroidal antiinflammatory agent | 0.207 0.066 CID_3651 | CID_3651 | |
| 0.138 | 0.017 | 0.138 | Glutamate (mGluR7) agonist | 0.1 0.06 CID_3651 | ||
| 0.125 | 0.004 | 0.139 | Sphingosine kinase 2 inhibitor | 0.139 0.004 CID_3651 | CID_3651 | |
| 0.158 | 0.038 | 0.158 | Histone deacetylase class III inhibitor | 0.149 0.044 CID_3651 | ||
| 0.131 | 0.011 | 0.131 | Ornithine carbamoyltransferase inhibitor | 0.107 0.015 CID_3651 | ||
| 0.138 | 0.02 | 0.138 | Chymotrypsin inhibitor | 0.106 0.032 CID_3651 | ||
| 0.145 | 0.027 | 0.145 | Sphingomyelinase inhibitor | 0.123 0.039 CID_3651 | ||
| 0.144 | 0.028 | 0.156 | HIV-1 integrase (Overall Integration) inhibitor | 0.156 0.023 CID_3651 | CID_3651 | |
| 0.124 | 0.009 | 0.174 | Opioid mu receptor agonist | 0.174 0.005 CID_3651 | CID_3651 | |
| 0.127 | 0.013 | 0.275 | Alcohol oxidase inhibitor | 0.275 0.005 CID_3651 | CID_3651 | |
| 0.125 | 0.012 | 0.125 | Bombesin 1 receptor agonist | 0.096 0.019 CID_3651 | ||
| 0.192 | 0.079 | 0.247 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.247 0.044 CID_3651 | CID_3651 | |
| 0.135 | 0.024 | 0.137 | Aminoacyl-tRNA synthetase inhibitor | 0.137 0.023 CID_3651 | CID_3651 | |
| 0.136 | 0.024 | 0.136 | Triose-phosphate isomerase inhibitor | 0.129 0.028 CID_3651 | ||
| 0.175 | 0.063 | 0.175 | Anticoagulant | 0.135 0.094 CID_3651 | ||
| 0.117 | 0.005 | 0.134 | Sphingosine kinase inhibitor | 0.134 0.004 CID_3651 | CID_3651 | |
| 0.124 | 0.012 | 0.124 | NMDA receptor agonist | 0.107 0.017 CID_3651 | ||
| 0.212 | 0.101 | 0.309 | Hypoglycemic | 0.309 0.05 CID_3651 | CID_3651 | |
| 0.133 | 0.022 | 0.147 | Phosphofructokinase-1 inhibitor | 0.147 0.019 CID_3651 | CID_3651 | |
| 0.17 | 0.061 | 0.17 | Diuretic | 0.151 0.077 CID_3651 | ||
| 0.114 | 0.004 | 0.114 | Glutamate (mGluR3) antagonist | 0.101 0.004 CID_3651 | ||
| 0.122 | 0.013 | 0.122 | Aminopeptidase microsomal inhibitor | 0.096 0.019 CID_3651 | ||
| 0.121 | 0.012 | 0.121 | Glycine receptor agonist | 0.12 0.013 CID_3651 | ||
| 0.113 | 0.005 | 0.113 | Glutamate (mGluR7) antagonist | 0.106 0.008 CID_3651 | ||
| 0.118 | 0.011 | 0.118 | Secretase beta inhibitor | 0.095 0.021 CID_3651 | ||
| 0.13 | 0.024 | 0.142 | NADH dehydrogenase inhibitor | 0.142 0.02 CID_3651 | CID_3651 | |
| 0.135 | 0.031 | 0.135 | 5 Hydroxytryptamine 2C antagonist | 0.081 0.06 CID_3651 | ||
| 0.106 | 0.004 | 0.106 | Immunoglobulin Fc receptor antagonist | 0.091 0.004 CID_3651 | ||
| 0.169 | 0.067 | 0.184 | Arachidonic acid antagonist | 0.184 0.05 CID_3651 | CID_3651 | |
| 0.122 | 0.02 | 0.122 | Glutamate release inhibitor | 0.114 0.026 CID_3651 | ||
| 0.12 | 0.018 | 0.12 | Protein kinase B alpha inhibitor | |||
| 0.132 | 0.03 | 0.212 | NMDA receptor antagonist | 0.212 0.013 CID_3651 | CID_3651 | |
| 0.131 | 0.03 | 0.149 | Anabolic | 0.149 0.018 CID_3651 | CID_3651 | |
| 0.104 | 0.003 | 0.104 | Kainate receptor agonist | 0.098 0.003 CID_3651 | ||
| 0.122 | 0.022 | 0.122 | Neuropeptide agonist | 0.107 0.025 CID_3651 | ||
| 0.135 | 0.035 | 0.148 | UDP-glucose 4-epimerase inhibitor | 0.148 0.029 CID_3651 | CID_3651 | |
| 0.162 | 0.064 | 0.195 | Phospholipase A2 inhibitor | 0.195 0.045 CID_3651 | CID_3651 | |
| 0.14 | 0.041 | 0.14 | 5 Hydroxytryptamine 3A agonist | 0.119 0.056 CID_3651 | ||
| 0.107 | 0.01 | 0.107 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.03 CID_3651 | ||
| 0.113 | 0.015 | 0.113 | Biliverdin reductase inhibitor | 0.086 0.023 CID_3651 | ||
| 0.121 | 0.025 | 0.121 | Protein kinase B gamma inhibitor | |||
| 0.108 | 0.012 | 0.154 | Glycine transporter 2 inhibitor | 0.154 0.007 CID_3651 | CID_3651 | |
| 0.185 | 0.089 | 0.223 | DNA methylase inhibitor | 0.223 0.064 CID_3651 | CID_3651 | |
| 0.1 | 0.004 | 0.1 | Glutamate (mGluR1) agonist | 0.063 0.004 CID_3651 | ||
| 0.106 | 0.01 | 0.106 | Dopamine transporter inhibitor | 0.066 0.022 CID_3651 | ||
| 0.101 | 0.005 | 0.101 | Glutamate (mGluR4) antagonist | 0.072 0.01 CID_3651 | ||
| 0.129 | 0.035 | 0.129 | Acetylcholine release stimulant | 0.099 0.089 CID_3651 | ||
| 0.097 | 0.004 | 0.097 | Histamine H2 receptor agonist | 0.058 0.016 CID_3651 | ||
| 0.097 | 0.004 | 0.097 | Dipeptidyl peptidase I inhibitor | 0.043 0.011 CID_3651 | ||
| 0.137 | 0.045 | 0.137 | Microtubule formation inhibitor | 0.135 0.046 CID_3651 | ||
| 0.204 | 0.112 | 0.214 | DNA damaging | 0.214 0.105 CID_3651 | CID_3651 | |
| 0.1 | 0.009 | 0.1 | Dipeptidyl peptidase inhibitor | 0.055 0.033 CID_3651 | ||
| 0.103 | 0.012 | 0.103 | Aminopeptidase N inhibitor | 0.073 0.019 CID_3651 | ||
| 0.143 | 0.052 | 0.206 | Aldehyde dehydrogenase inhibitor | 0.206 0.026 CID_3651 | CID_3651 | |
| 0.156 | 0.066 | 0.185 | CF transmembrane conductance regulator agonist | 0.185 0.032 CID_3651 | CID_3651 | |
| 0.14 | 0.05 | 0.14 | Acetylcholine muscarinic antagonist | 0.138 0.052 CID_3651 | ||
| 0.094 | 0.005 | 0.156 | Dopamine D5 agonist | 0.156 0.003 CID_3651 | CID_3651 | |
| 0.166 | 0.077 | 0.166 | Antipruritic | 0.161 0.083 CID_3651 | ||
| 0.122 | 0.033 | 0.187 | Alcohol dehydrogenase inhibitor | 0.187 0.014 CID_3651 | CID_3651 | |
| 0.102 | 0.013 | 0.138 | Opioid agonist | 0.138 0.008 CID_3651 | CID_3651 | |
| 0.111 | 0.025 | 0.196 | Keratolytic | 0.196 0.009 CID_3651 | CID_3651 | |
| 0.104 | 0.02 | 0.136 | Estrogen-related receptor beta agonist | 0.136 0.005 CID_3651 | CID_3651 | |
| 0.119 | 0.036 | 0.119 | Calcium antagonist | |||
| 0.136 | 0.053 | 0.278 | Monophenol monooxygenase inhibitor | 0.278 0.02 CID_3651 | CID_3651 | |
| 0.108 | 0.025 | 0.108 | Nicotinic alpha4beta2 receptor antagonist | 0.069 0.064 CID_3651 | ||
| 0.111 | 0.028 | 0.116 | Glutathione S-transferase inhibitor | 0.116 0.025 CID_3651 | CID_3651 | |
| 0.095 | 0.013 | 0.095 | Bombesin 3 receptor antagonist | 0.071 0.024 CID_3651 | ||
| 0.149 | 0.067 | 0.164 | Cell wall synthesis inhibitor | 0.164 0.053 CID_3651 | CID_3651 | |
| 0.095 | 0.013 | 0.095 | Kallikrein 1 inhibitor | 0.07 0.024 CID_3651 | ||
| 0.085 | 0.003 | 0.085 | Histamine H1 receptor agonist | 0.054 0.013 CID_3651 | ||
| 0.13 | 0.048 | 0.145 | TRPA1 agonist | 0.145 0.035 CID_3651 | CID_3651 | |
| 0.096 | 0.014 | 0.138 | NMDA 2A receptor antagonist | 0.138 0.008 CID_3651 | CID_3651 | |
| 0.086 | 0.005 | 0.09 | Sphingosine kinase 1 inhibitor | 0.09 0.004 CID_3651 | CID_3651 | |
| 0.088 | 0.006 | 0.088 | Glutamate (mGluR group III) antagonist | 0.066 0.01 CID_3651 | ||
| 0.091 | 0.011 | 0.091 | Sphingosine 1-phosphate receptor 3 antagonist | 0.09 0.011 CID_3651 | ||
| 0.11 | 0.03 | 0.11 | Factor XII inhibitor | 0.096 0.042 CID_3651 | ||
| 0.097 | 0.017 | 0.119 | NMDA 2C receptor antagonist | 0.119 0.011 CID_3651 | CID_3651 | |
| 0.1 | 0.022 | 0.1 | Sirtuin 1 inhibitor | 0.099 0.023 CID_3651 | ||
| 0.143 | 0.066 | 0.143 | Neurotrophic factor | 0.139 0.069 CID_3651 | ||
| 0.088 | 0.011 | 0.088 | Histamine agonist | |||
| 0.144 | 0.067 | 0.241 | Amylase inhibitor | 0.241 0.031 CID_3651 | CID_3651 | |
| 0.115 | 0.039 | 0.117 | Interleukin 1 beta converting enzyme inhibitor | 0.117 0.038 CID_3651 | CID_3651 | |
| 0.082 | 0.006 | 0.082 | AMPA 4 receptor antagonist | 0.081 0.006 CID_3651 | ||
| 0.091 | 0.015 | 0.091 | Bombesin 2 receptor antagonist | 0.084 0.016 CID_3651 | ||
| 0.081 | 0.005 | 0.081 | Diamine oxidase inhibitor | 0.051 0.014 CID_3651 | ||
| 0.108 | 0.032 | 0.108 | Glutamate receptor agonist | |||
| 0.08 | 0.005 | 0.08 | Endothelial nitric-oxide synthase inhibitor | 0.035 0.017 CID_3651 | ||
| 0.094 | 0.019 | 0.094 | Phospholipase D inhibitor | 0.072 0.048 CID_3651 | ||
| 0.119 | 0.045 | 0.119 | Falcipain inhibitor | 0.1 0.054 CID_3651 | ||
| 0.081 | 0.006 | 0.081 | Kainate receptor 2 antagonist | 0.057 0.013 CID_3651 | ||
| 0.093 | 0.019 | 0.093 | Human rhinovirus A protease inhibitor | 0.066 0.031 CID_3651 | ||
| 0.097 | 0.023 | 0.097 | Glucagon-like peptide 1 agonist | 0.093 0.026 CID_3651 | ||
| 0.077 | 0.005 | 0.077 | Dipeptidyl peptidase II inhibitor | 0.039 0.015 CID_3651 | ||
| 0.127 | 0.055 | 0.127 | Calcium channel N-type blocker | |||
| 0.093 | 0.02 | 0.116 | MAP kinase kinase 7 inhibitor | 0.116 0.005 CID_3651 | CID_3651 | |
| 0.1 | 0.028 | 0.1 | Alpha adrenoreceptor agonist | 0.087 0.034 CID_3651 | ||
| 0.091 | 0.02 | 0.109 | Purinergic P2X1 antagonist | 0.109 0.014 CID_3651 | CID_3651 | |
| 0.093 | 0.022 | 0.115 | GABA B receptor agonist | 0.115 0.009 CID_3651 | CID_3651 | |
| 0.224 | 0.153 | 0.298 | Apoptosis antagonist | 0.298 0.087 CID_3651 | CID_3651 | |
| 0.075 | 0.004 | 0.075 | Glutamate (mGluR8) agonist | 0.071 0.005 CID_3651 | ||
| 0.074 | 0.003 | 0.074 | Tryptophan 5 hydroxylase inhibitor | 0.057 0.004 CID_3651 | ||
| 0.079 | 0.009 | 0.101 | Beta 2 adrenoreceptor agonist | 0.101 0.004 CID_3651 | CID_3651 | |
| 0.091 | 0.021 | 0.116 | Ribonucleoside-diphosphate reductase inhibitor | 0.116 0.016 CID_3651 | CID_3651 | |
| 0.074 | 0.004 | 0.074 | Glutamate (mGluR1a) agonist | 0.042 0.005 CID_3651 | ||
| 0.077 | 0.008 | 0.077 | Dipeptidyl peptidase IV inhibitor | 0.044 0.031 CID_3651 | ||
| 0.089 | 0.02 | 0.089 | Glutamate (mGluR1) antagonist | 0.05 0.048 CID_3651 | ||
| 0.121 | 0.052 | 0.128 | Protein kinase C gamma inhibitor | 0.128 0.046 CID_3651 | CID_3651 | |
| 0.113 | 0.045 | 0.113 | Falcipain 2 inhibitor | 0.096 0.054 CID_3651 | ||
| 0.092 | 0.024 | 0.092 | Vanilloid 4 agonist | 0.071 0.062 CID_3651 | ||
| 0.091 | 0.023 | 0.114 | Ribonucleotide reductase inhibitor | 0.114 0.018 CID_3651 | CID_3651 | |
| 0.08 | 0.012 | 0.08 | Epithelial sodium channel blocker | 0.075 0.015 CID_3651 | ||
| 0.157 | 0.089 | 0.162 | ATPase inhibitor | 0.162 0.082 CID_3651 | CID_3651 | |
| 0.1 | 0.032 | 0.1 | Glycine receptor antagonist | 0.079 0.058 CID_3651 | ||
| 0.074 | 0.006 | 0.074 | Growth hormone releasing factor agonist | |||
| 0.077 | 0.01 | 0.077 | Kainate receptor antagonist | 0.068 0.013 CID_3651 | ||
| 0.083 | 0.016 | 0.083 | Histone deacetylase SIRT3 inhibitor | 0.073 0.024 CID_3651 | ||
| 0.074 | 0.008 | 0.074 | GHS receptor agonist | 0.05 0.02 CID_3651 | ||
| 0.088 | 0.022 | 0.088 | Dopamine uptake inhibitor | 0.062 0.036 CID_3651 | ||
| 0.085 | 0.02 | 0.085 | Acyl-CoA dehydrogenase inhibitor | 0.065 0.03 CID_3651 | ||
| 0.078 | 0.013 | 0.078 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.036 CID_3651 | ||
| 0.13 | 0.065 | 0.13 | Cholinergic antagonist | 0.121 0.073 CID_3651 | ||
| 0.076 | 0.011 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.066 0.017 CID_3651 | ||
| 0.127 | 0.064 | 0.127 | Acetylcholine antagonist | 0.118 0.072 CID_3651 | ||
| 0.08 | 0.017 | 0.08 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.098 | 0.036 | 0.164 | Opioid kappa receptor antagonist | 0.164 0.014 CID_3651 | CID_3651 | |
| 0.077 | 0.015 | 0.077 | Aconitate hydratase inhibitor | 0.06 0.026 CID_3651 | ||
| 0.155 | 0.093 | 0.155 | LIM domain kinase 1 inhibitor | 0.128 0.124 CID_3651 | ||
| 0.07 | 0.008 | 0.07 | Fumarate hydratase inhibitor | 0.06 0.01 CID_3651 | ||
| 0.103 | 0.042 | 0.116 | Bile acid receptor antagonist | 0.116 0.023 CID_3651 | CID_3651 | |
| 0.093 | 0.032 | 0.101 | CC chemokine 5 receptor agonist | 0.101 0.021 CID_3651 | CID_3651 | |
| 0.092 | 0.031 | 0.092 | Thrombin inhibitor | 0.069 0.056 CID_3651 | ||
| 0.119 | 0.059 | 0.119 | Alpha 2b adrenoreceptor antagonist | 0.092 0.083 CID_3651 | ||
| 0.119 | 0.059 | 0.119 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.085 | 0.025 | 0.085 | NMDA receptor glycine site agonist | 0.065 0.041 CID_3651 | ||
| 0.083 | 0.024 | 0.083 | Plasminogen activator inhibitor | 0.074 0.029 CID_3651 | ||
| 0.126 | 0.067 | 0.126 | Nav1.3 sodium channel blocker | |||
| 0.081 | 0.022 | 0.081 | Cathepsin E inhibitor | 0.068 0.031 CID_3651 | ||
| 0.207 | 0.148 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.104 | 0.046 | 0.127 | Protein kinase C zeta inhibitor | 0.127 0.028 CID_3651 | CID_3651 | |
| 0.195 | 0.137 | 0.195 | MAP kinase kinase 3 inhibitor | |||
| 0.08 | 0.023 | 0.118 | Beta 3 adrenoreceptor antagonist | 0.118 0.01 CID_3651 | CID_3651 | |
| 0.066 | 0.008 | 0.095 | Opioid delta receptor agonist | 0.095 0.005 CID_3651 | CID_3651 | |
| 0.108 | 0.052 | 0.108 | Folate antagonist | 0.098 0.069 CID_3651 | ||
| 0.065 | 0.009 | 0.07 | Arginase inhibitor | 0.07 0.008 CID_3651 | CID_3651 | |
| 0.071 | 0.015 | 0.071 | Prolyl endopeptidase inhibitor | 0.056 0.028 CID_3651 | ||
| 0.122 | 0.066 | 0.138 | Alkylator | 0.138 0.053 CID_3651 | CID_3651 | |
| 0.065 | 0.01 | 0.065 | Geranyltranstransferase inhibitor | 0.06 0.014 CID_3651 | ||
| 0.096 | 0.041 | 0.105 | Myeloperoxidase inhibitor | 0.105 0.03 CID_3651 | CID_3651 | |
| 0.091 | 0.037 | 0.091 | Interferon agonist | 0.081 0.051 CID_3651 | ||
| 0.07 | 0.016 | 0.07 | Alpha-mannosidase inhibitor | 0.07 0.017 CID_3651 | ||
| 0.08 | 0.026 | 0.08 | Exportin-1 inhibitor | |||
| 0.132 | 0.078 | 0.132 | Cytokine production inhibitor | |||
| 0.069 | 0.016 | 0.143 | NMDA receptor subunit 3B antagonist | 0.143 0.007 CID_3651 | CID_3651 | |
| 0.063 | 0.01 | 0.063 | VLA-4 antagonist | 0.049 0.013 CID_3651 | ||
| 0.071 | 0.017 | 0.071 | Complement C3a chemotactic receptor antagonist | 0.052 0.026 CID_3651 | ||
| 0.068 | 0.015 | 0.119 | NMDA receptor subunit 3A antagonist | 0.119 0.007 CID_3651 | CID_3651 | |
| 0.115 | 0.063 | 0.115 | Sphingosine 1-phosphate receptor 2 agonist | 0.109 0.078 CID_3651 | ||
| 0.065 | 0.013 | 0.065 | Somatostatin 1 antagonist | 0.06 0.015 CID_3651 | ||
| 0.078 | 0.026 | 0.078 | Cathepsin L inhibitor | 0.061 0.037 CID_3651 | ||
| 0.06 | 0.008 | 0.073 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.073 0.004 CID_3651 | CID_3651 | |
| 0.078 | 0.026 | 0.078 | Cathepsin D inhibitor | 0.052 0.04 CID_3651 | ||
| 0.063 | 0.011 | 0.063 | Cytokine production stimulant | 0.05 0.029 CID_3651 | ||
| 0.107 | 0.056 | 0.141 | Bronchodilator | 0.141 0.034 CID_3651 | CID_3651 | |
| 0.241 | 0.19 | 0.241 | Analgesic | 0.223 0.211 CID_3651 | ||
| 0.103 | 0.053 | 0.103 | Electrolyte absorption antagonist | |||
| 0.064 | 0.014 | 0.07 | Oxytocin agonist | 0.07 0.01 CID_3651 | CID_3651 | |
| 0.073 | 0.023 | 0.076 | Botulinum neurotoxin type A inhibitor | 0.076 0.02 CID_3651 | CID_3651 | |
| 0.132 | 0.082 | 0.179 | Protein kinase stimulant | 0.179 0.05 CID_3651 | CID_3651 | |
| 0.065 | 0.015 | 0.065 | Cathepsin L2 inhibitor | 0.052 0.021 CID_3651 | ||
| 0.054 | 0.004 | 0.054 | Aminopeptidase P inhibitor | 0.036 0.007 CID_3651 | ||
| 0.067 | 0.018 | 0.067 | Glutamate (mGluR group I) agonist | |||
| 0.093 | 0.044 | 0.15 | Carbonic anhydrase VI inhibitor | 0.15 0.021 CID_3651 | CID_3651 | |
| 0.054 | 0.005 | 0.054 | Methionyl aminopeptidase 1 inhibitor | 0.039 0.013 CID_3651 | ||
| 0.08 | 0.032 | 0.08 | Neutrophil collagenase inhibitor | 0.078 0.033 CID_3651 | ||
| 0.082 | 0.033 | 0.082 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.072 | 0.024 | 0.072 | Urokinase inhibitor | 0.055 0.03 CID_3651 | ||
| 0.053 | 0.005 | 0.053 | Growth hormone release promoting | |||
| 0.058 | 0.01 | 0.058 | Sirtuin 2 inhibitor | 0.045 0.015 CID_3651 | ||
| 0.107 | 0.059 | 0.123 | Urease inhibitor | 0.123 0.042 CID_3651 | CID_3651 | |
| 0.057 | 0.009 | 0.057 | Phenylethanolamine N methyltransferase inhibitor | 0.049 0.015 CID_3651 | ||
| 0.066 | 0.019 | 0.066 | Toll-Like receptor 2 agonist | 0.055 0.021 CID_3651 | ||
| 0.059 | 0.012 | 0.059 | Somatostatin 2 antagonist | 0.047 0.016 CID_3651 | ||
| 0.064 | 0.017 | 0.064 | Nicotinic receptor alpha3 subunit antagonist | 0.046 0.028 CID_3651 | ||
| 0.091 | 0.044 | 0.091 | 3C-Like protease (SARS coronavirus) inhibitor | 0.084 0.059 CID_3651 | ||
| 0.069 | 0.023 | 0.069 | Cyclin A1 inhibitor | |||
| 0.068 | 0.022 | 0.068 | Angiotensin-converting enzyme inhibitor | 0.063 0.026 CID_3651 | ||
| 0.051 | 0.005 | 0.062 | Glutamate (mGluR3) agonist | 0.062 0.004 CID_3651 | CID_3651 | |
| 0.071 | 0.025 | 0.089 | Beta 1 adrenoreceptor antagonist | 0.089 0.013 CID_3651 | CID_3651 | |
| 0.171 | 0.125 | 0.171 | Platelet antagonist | 0.169 0.127 CID_3651 | ||
| 0.076 | 0.03 | 0.107 | Beta adrenoreceptor antagonist | 0.107 0.014 CID_3651 | CID_3651 | |
| 0.075 | 0.029 | 0.075 | Interferon inducer | 0.065 0.043 CID_3651 | ||
| 0.063 | 0.017 | 0.063 | Glutamate (mGluR group III) agonist | 0.044 0.029 CID_3651 | ||
| 0.15 | 0.104 | 0.194 | DNA methyltransferase I inhibitor | 0.194 0.072 CID_3651 | CID_3651 | |
| 0.055 | 0.01 | 0.055 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.028 CID_3651 | ||
| 0.091 | 0.047 | 0.091 | Hematopoietic | 0.089 0.052 CID_3651 | ||
| 0.061 | 0.016 | 0.061 | Mannosidase inhibitor | 0.06 0.017 CID_3651 | ||
| 0.053 | 0.008 | 0.053 | Thrombin receptor antagonist | 0.03 0.017 CID_3651 | ||
| 0.061 | 0.017 | 0.061 | Bombesin antagonist | 0.052 0.026 CID_3651 | ||
| 0.058 | 0.014 | 0.058 | Neurokinin 2 agonist | 0.04 0.031 CID_3651 | ||
| 0.052 | 0.008 | 0.052 | AMPA receptor agonist | 0.041 0.016 CID_3651 | ||
| 0.052 | 0.008 | 0.052 | Glutamate (mGluR8) antagonist | 0.046 0.011 CID_3651 | ||
| 0.074 | 0.03 | 0.074 | Trypsin inhibitor | 0.061 0.045 CID_3651 | ||
| 0.052 | 0.008 | 0.052 | AMPA 3 receptor antagonist | 0.046 0.01 CID_3651 | ||
| 0.2 | 0.157 | 0.2 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.184 0.177 CID_3651 | ||
| 0.059 | 0.017 | 0.059 | Melanocortin 1 antagonist | 0.041 0.024 CID_3651 | ||
| 0.063 | 0.021 | 0.087 | Beta 2 adrenoreceptor antagonist | 0.087 0.01 CID_3651 | CID_3651 | |
| 0.056 | 0.014 | 0.056 | Plasmepsin II inhibitor | 0.047 0.02 CID_3651 | ||
| 0.059 | 0.017 | 0.068 | Dopamine beta hydroxylase inhibitor | 0.068 0.009 CID_3651 | CID_3651 | |
| 0.061 | 0.02 | 0.061 | Adenosine deaminase inhibitor | 0.06 0.021 CID_3651 | ||
| 0.142 | 0.101 | 0.165 | Interleukin 6 antagonist | 0.165 0.07 CID_3651 | CID_3651 | |
| 0.112 | 0.072 | 0.114 | Caspase 3 inhibitor | 0.114 0.069 CID_3651 | CID_3651 | |
| 0.051 | 0.012 | 0.051 | Somatostatin 5 agonist | 0.04 0.019 CID_3651 | ||
| 0.068 | 0.03 | 0.068 | Cathepsin B inhibitor | 0.05 0.048 CID_3651 | ||
| 0.052 | 0.014 | 0.073 | Beta adrenoreceptor agonist | 0.073 0.005 CID_3651 | CID_3651 | |
| 0.052 | 0.014 | 0.052 | Membrane dipeptidase inhibitor | 0.041 0.025 CID_3651 | ||
| 0.065 | 0.026 | 0.065 | Plasmin inhibitor | 0.045 0.035 CID_3651 | ||
| 0.166 | 0.128 | 0.173 | Cyclic AMP phosphodiesterase inhibitor | 0.173 0.119 CID_3651 | CID_3651 | |
| 0.12 | 0.082 | 0.149 | Papain-like protease (SARS coronavirus) inhibitor | 0.149 0.035 CID_3651 | CID_3651 | |
| 0.056 | 0.018 | 0.056 | Growth hormone release inhibitor | 0.053 0.019 CID_3651 | ||
| 0.158 | 0.12 | 0.158 | Anticonvulsant | |||
| 0.209 | 0.172 | 0.209 | Ca(v)3.3 blocker | |||
| 0.041 | 0.004 | 0.043 | Vanilloid 2 agonist | 0.043 0.004 CID_3651 | CID_3651 | |
| 0.053 | 0.016 | 0.059 | Calcitonin receptor agonist | 0.059 0.015 CID_3651 | CID_3651 | |
| 0.044 | 0.007 | 0.044 | Adenosine uptake inhibitor | 0.034 0.027 CID_3651 | ||
| 0.062 | 0.026 | 0.062 | Protease activated receptor 1 antagonist | |||
| 0.08 | 0.044 | 0.138 | NMDA 2 receptor antagonist | 0.138 0.019 CID_3651 | CID_3651 | |
| 0.084 | 0.048 | 0.084 | Cell adhesion molecule inhibitor | |||
| 0.048 | 0.012 | 0.048 | Integrin alpha4 antagonist | 0.024 0.018 CID_3651 | ||
| 0.054 | 0.018 | 0.054 | Cathepsin L1 inhibitor | |||
| 0.054 | 0.018 | 0.054 | Leukotriene A4 hydrolase inhibitor | 0.04 0.025 CID_3651 | ||
| 0.085 | 0.05 | 0.085 | Acetylcholine nicotinic antagonist | |||
| 0.068 | 0.034 | 0.068 | Alpha 2 adrenoreceptor agonist | 0.055 0.049 CID_3651 | ||
| 0.045 | 0.011 | 0.045 | Trypsin II inhibitor | 0.027 0.025 CID_3651 | ||
| 0.048 | 0.015 | 0.048 | Cathepsin F inhibitor | |||
| 0.056 | 0.023 | 0.056 | Melanocortin antagonist | |||
| 0.037 | 0.005 | 0.037 | Dipeptidyl peptidase IX inhibitor | 0.017 0.01 CID_3651 | ||
| 0.076 | 0.044 | 0.076 | Potassium channel (Tandem pore domain) blocker | |||
| 0.155 | 0.123 | 0.155 | Focal adhesion kinase 2 inhibitor | |||
| 0.053 | 0.022 | 0.053 | Melanocortin 4 antagonist | |||
| 0.146 | 0.116 | 0.185 | Catenin beta inhibitor | 0.185 0.046 CID_3651 | CID_3651 | |
| 0.046 | 0.016 | 0.046 | Potassium channel Kv1.1 blocker | |||
| 0.065 | 0.035 | 0.066 | Prolactin release inhibitor | 0.066 0.032 CID_3651 | CID_3651 | |
| 0.045 | 0.015 | 0.045 | VCAM-1 antagonist | 0.044 0.017 CID_3651 | ||
| 0.044 | 0.015 | 0.044 | VCAM antagonist | 0.043 0.017 CID_3651 | ||
| 0.09 | 0.061 | 0.09 | Polo-like kinase-1 inhibitor | |||
| 0.093 | 0.064 | 0.133 | MAO B inhibitor | 0.133 0.044 CID_3651 | CID_3651 | |
| 0.055 | 0.025 | 0.07 | Neurotensin receptor antagonist | 0.07 0.02 CID_3651 | CID_3651 | |
| 0.047 | 0.018 | 0.047 | Kinesin antagonist | 0.047 0.017 CID_3651 | ||
| 0.047 | 0.018 | 0.047 | Kinesin-like protein 1 inhibitor | 0.047 0.017 CID_3651 | ||
| 0.085 | 0.055 | 0.106 | D-Ala-D-Ala ligase inhibitor | 0.106 0.023 CID_3651 | CID_3651 | |
| 0.037 | 0.008 | 0.037 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.036 0.009 CID_3651 | ||
| 0.124 | 0.095 | 0.124 | Mannose-6-phosphate isomerase inhibitor | 0.118 0.105 CID_3651 | ||
| 0.081 | 0.052 | 0.087 | Metalloproteinase-2 inhibitor | 0.087 0.046 CID_3651 | CID_3651 | |
| 0.049 | 0.02 | 0.049 | Sphingosine 1-phosphate receptor 1 agonist | 0.045 0.026 CID_3651 | ||
| 0.032 | 0.003 | 0.032 | Tryptophan hydroxylase 1 inhibitor | 0.025 0.004 CID_3651 | ||
| 0.056 | 0.028 | 0.056 | Antimetabolite | 0.049 0.032 CID_3651 | ||
| 0.037 | 0.008 | 0.037 | Kainate receptor 1 antagonist | 0.028 0.011 CID_3651 | ||
| 0.034 | 0.005 | 0.034 | Aminopeptidase A inhibitor | 0.03 0.006 CID_3651 | ||
| 0.037 | 0.009 | 0.037 | Motilin receptor antagonist | 0.033 0.011 CID_3651 | ||
| 0.053 | 0.026 | 0.053 | Histamine H4 receptor antagonist | |||
| 0.071 | 0.044 | 0.071 | Neuronal nicotinic receptor antagonist | |||
| 0.059 | 0.032 | 0.059 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 CID_3651 | ||
| 0.037 | 0.01 | 0.037 | Methionyl aminopeptidase 2 inhibitor | 0.022 0.021 CID_3651 | ||
| 0.031 | 0.004 | 0.032 | Neuraminidase (Influenza B) inhibitor | 0.032 0.004 CID_3651 | CID_3651 | |
| 0.07 | 0.044 | 0.07 | Matrix metalloproteinase inhibitor | 0.07 0.044 CID_3651 | ||
| 0.056 | 0.029 | 0.066 | Vanilloid 2 antagonist | 0.066 0.017 CID_3651 | CID_3651 | |
| 0.034 | 0.008 | 0.034 | Integrin alpha4beta7 antagonist | 0.023 0.013 CID_3651 | ||
| 0.04 | 0.015 | 0.041 | AMPA 1 receptor antagonist | 0.041 0.014 CID_3651 | CID_3651 | |
| 0.085 | 0.059 | 0.091 | Transcription factor NF kappa B stimulant | 0.091 0.05 CID_3651 | CID_3651 | |
| 0.03 | 0.005 | 0.03 | Dipeptidyl peptidase VIII inhibitor | 0.014 0.013 CID_3651 | ||
| 0.078 | 0.053 | 0.088 | Na+ K+ transporting ATPase inhibitor | 0.088 0.043 CID_3651 | CID_3651 | |
| 0.048 | 0.023 | 0.048 | HIV-1 protease inhibitor | 0.048 0.024 CID_3651 | ||
| 0.03 | 0.005 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 CID_3651 | ||
| 0.06 | 0.035 | 0.074 | Carbonic anhydrase VB inhibitor | 0.074 0.025 CID_3651 | CID_3651 | |
| 0.038 | 0.014 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.031 0.02 CID_3651 | ||
| 0.035 | 0.01 | 0.035 | Purinergic P2Y15 antagonist | 0.031 0.015 CID_3651 | ||
| 0.043 | 0.019 | 0.043 | Bombesin 1 receptor antagonist | 0.033 0.031 CID_3651 | ||
| 0.139 | 0.115 | 0.139 | Tumour necrosis factor antagonist | 0.134 0.122 CID_3651 | ||
| 0.029 | 0.004 | 0.043 | Nicotinic acid receptor 1 antagonist | 0.043 0.003 CID_3651 | CID_3651 | |
| 0.113 | 0.088 | 0.113 | DNA repair enzyme inhibitor | 0.111 0.093 CID_3651 | ||
| 0.036 | 0.012 | 0.036 | Lysine carboxypeptidase inhibitor | 0.036 0.012 CID_3651 | ||
| 0.084 | 0.06 | 0.105 | Vanilloid agonist | 0.105 0.028 CID_3651 | CID_3651 | |
| 0.038 | 0.014 | 0.038 | Carboxypeptidase B inhibitor | 0.035 0.019 CID_3651 | ||
| 0.052 | 0.029 | 0.052 | Endothelin-converting enzyme inhibitor | |||
| 0.04 | 0.016 | 0.04 | Glutamate (mGluR4) agonist | 0.033 0.025 CID_3651 | ||
| 0.144 | 0.121 | 0.22 | Pyruvate kinase inhibitor | 0.22 0.071 CID_3651 | CID_3651 | |
| 0.041 | 0.018 | 0.041 | Somatostatin 5 antagonist | 0.038 0.019 CID_3651 | ||
| 0.031 | 0.008 | 0.031 | Acid ceramidase inhibitor | |||
| 0.064 | 0.042 | 0.064 | Calcium channel P-type blocker | |||
| 0.032 | 0.009 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.022 CID_3651 | ||
| 0.082 | 0.06 | 0.082 | Histamine H2 receptor antagonist | |||
| 0.057 | 0.035 | 0.057 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.04 CID_3651 | ||
| 0.073 | 0.051 | 0.073 | Histone deacetylase SIRT2 inhibitor | |||
| 0.054 | 0.032 | 0.054 | Carbonic anhydrase II stimulant | |||
| 0.042 | 0.021 | 0.042 | Growth hormone secretagogue receptor antagonist | |||
| 0.037 | 0.016 | 0.037 | AMPA 2 receptor antagonist | 0.031 0.019 CID_3651 | ||
| 0.047 | 0.026 | 0.047 | Leukocyte elastase inhibitor | |||
| 0.036 | 0.016 | 0.036 | Calpain 1 inhibitor | 0.032 0.028 CID_3651 | ||
| 0.072 | 0.052 | 0.079 | Metalloproteinase-9 inhibitor | 0.079 0.045 CID_3651 | CID_3651 | |
| 0.029 | 0.009 | 0.029 | Complement factor 1s inhibitor | |||
| 0.029 | 0.008 | 0.029 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.113 | 0.093 | 0.113 | Antibacterial (Helicobacter pylori) | 0.109 0.1 CID_3651 | ||
| 0.033 | 0.013 | 0.033 | 5 Hydroxytryptamine 6 agonist | |||
| 0.028 | 0.007 | 0.028 | Histamine H4 receptor agonist | |||
| 0.041 | 0.022 | 0.041 | Cholecystokinin B agonist | 0.037 0.026 CID_3651 | ||
| 0.046 | 0.027 | 0.047 | AICAR transformylase inhibitor | 0.047 0.026 CID_3651 | CID_3651 | |
| 0.05 | 0.03 | 0.05 | Kallikrein inhibitor | |||
| 0.057 | 0.038 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.073 | 0.054 | 0.073 | Rho-associated kinase I inhibitor | |||
| 0.054 | 0.036 | 0.058 | Matrix metalloproteinase 1 inhibitor | 0.058 0.033 CID_3651 | CID_3651 | |
| 0.028 | 0.01 | 0.028 | Integrin beta7 antagonist | 0.019 0.014 CID_3651 | ||
| 0.05 | 0.032 | 0.05 | Collagenase inhibitor | |||
| 0.047 | 0.029 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.023 CID_3651 | CID_3651 | |
| 0.045 | 0.027 | 0.045 | GABA B receptor antagonist | 0.039 0.037 CID_3651 | ||
| 0.078 | 0.06 | 0.078 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.038 | 0.02 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 CID_3651 | ||
| 0.093 | 0.076 | 0.097 | Nav1.1 sodium channel blocker | 0.097 0.07 CID_3651 | CID_3651 | |
| 0.222 | 0.205 | 0.292 | Antibacterial | 0.292 0.142 CID_3651 | CID_3651 | |
| 0.03 | 0.013 | 0.051 | Thyroid hormone agonist | 0.051 0.004 CID_3651 | CID_3651 | |
| 0.04 | 0.023 | 0.04 | Factor XIIIa inhibitor | |||
| 0.05 | 0.033 | 0.05 | Metalloproteinase-3 inhibitor | 0.044 0.04 CID_3651 | ||
| 0.036 | 0.02 | 0.036 | Angiotensin II receptor antagonist | |||
| 0.034 | 0.017 | 0.034 | Plasmepsin I inhibitor | |||
| 0.078 | 0.062 | 0.078 | Protein kinase A inhibitor | |||
| 0.047 | 0.031 | 0.047 | Adenylate cyclase 1 inhibitor | 0.042 0.038 CID_3651 | ||
| 0.055 | 0.04 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.039 CID_3651 | ||
| 0.021 | 0.006 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_3651 | CID_3651 | |
| 0.102 | 0.087 | 0.102 | Beta amyloid protein antagonist | |||
| 0.034 | 0.019 | 0.034 | GHS receptor antagonist | |||
| 0.036 | 0.021 | 0.036 | Plasma kallikrein inhibitor | |||
| 0.066 | 0.051 | 0.066 | MDM2 inhibitor | |||
| 0.049 | 0.035 | 0.049 | HCV NS3/NS4A protease inhibitor | |||
| 0.046 | 0.032 | 0.046 | Glutamate (mGluR5) agonist | |||
| 0.044 | 0.031 | 0.044 | Sphingosine 1-phosphate receptor agonist | |||
| 0.018 | 0.005 | 0.019 | Glutamate (mGluR6) agonist | 0.019 0.004 CID_3651 | CID_3651 | |
| 0.041 | 0.028 | 0.049 | Erythropoietin receptor agonist | 0.049 0.022 CID_3651 | CID_3651 | |
| 0.032 | 0.019 | 0.032 | Peptide deformylase inhibitor | |||
| 0.029 | 0.016 | 0.029 | Urotensin II agonist | 0.027 0.018 CID_3651 | ||
| 0.025 | 0.012 | 0.025 | Neurokinin 1 agonist | 0.018 0.016 CID_3651 | ||
| 0.043 | 0.03 | 0.043 | Heme oxygenase inhibitor | |||
| 0.036 | 0.023 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.024 CID_3651 | ||
| 0.061 | 0.048 | 0.061 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.026 | 0.014 | 0.026 | Somatostatin 4 antagonist | 0.023 0.017 CID_3651 | ||
| 0.037 | 0.025 | 0.037 | Renin inhibitor | |||
| 0.03 | 0.018 | 0.03 | Histamine H3 receptor agonist | |||
| 0.058 | 0.046 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.049 | 0.038 | 0.049 | Potassium channel (Inward rectifier) activator | |||
| 0.047 | 0.036 | 0.047 | Sigma receptor antagonist | |||
| 0.123 | 0.113 | 0.123 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.038 | 0.027 | 0.038 | Factor VIIa inhibitor | |||
| 0.024 | 0.013 | 0.024 | ICAM 1 antagonist | 0.022 0.017 CID_3651 | ||
| 0.047 | 0.036 | 0.047 | Potassium channel (ATP-sensitive) activator | |||
| 0.037 | 0.027 | 0.037 | Carbonic anhydrase I stimulant | |||
| 0.04 | 0.03 | 0.04 | Histone deacetylase 8 inhibitor | |||
| 0.041 | 0.031 | 0.041 | Angiotensin AT1 receptor antagonist | |||
| 0.059 | 0.049 | 0.059 | I kappa B kinase 2 inhibitor | 0.057 0.054 CID_3651 | ||
| 0.038 | 0.029 | 0.038 | GABA uptake inhibitor | |||
| 0.073 | 0.064 | 0.073 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.062 CID_3651 | ||
| 0.027 | 0.018 | 0.027 | Calcium-sensing receptor agonist | |||
| 0.022 | 0.013 | 0.022 | Imidazoline I1 receptor antagonist | |||
| 0.046 | 0.037 | 0.046 | Glucose-6-phosphate isomerase inhibitor | 0.045 0.038 CID_3651 | ||
| 0.027 | 0.018 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.02 | 0.011 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 CID_3651 | CID_3651 | |
| 0.017 | 0.009 | 0.017 | CXC chemokine 4 receptor agonist | |||
| 0.056 | 0.048 | 0.059 | Gonadotropin-releasing hormone receptor agonist | 0.059 0.042 CID_3651 | CID_3651 | |
| 0.063 | 0.055 | 0.063 | Potassium channel (ATP-sensitive) blocker | |||
| 0.098 | 0.09 | 0.126 | Cholesterol synthesis inhibitor | 0.126 0.06 CID_3651 | CID_3651 | |
| 0.023 | 0.015 | 0.023 | Bombesin agonist | |||
| 0.019 | 0.012 | 0.03 | Estrogen-related receptor gamma agonist | 0.03 0.004 CID_3651 | CID_3651 | |
| 0.015 | 0.008 | 0.015 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.026 | 0.019 | 0.026 | Sigma 1 receptor antagonist | |||
| 0.042 | 0.035 | 0.042 | Dihydroorotase inhibitor | |||
| 0.022 | 0.016 | 0.022 | Geranylgeranyltransferase inhibitor | |||
| 0.02 | 0.014 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.023 | 0.017 | 0.023 | Growth hormone releasing factor antagonist | 0.022 0.018 CID_3651 | ||
| 0.027 | 0.021 | 0.027 | Hedgehog signaling activator | 0.026 0.025 CID_3651 | ||
| 0.085 | 0.079 | 0.085 | MAP kinase kinase 1 inhibitor | |||
| 0.044 | 0.038 | 0.044 | AMPA receptor antagonist | |||
| 0.058 | 0.052 | 0.058 | Caspase 9 inhibitor | |||
| 0.011 | 0.006 | 0.011 | Angiotensin AT2 receptor agonist | |||
| 0.026 | 0.021 | 0.026 | Myristoyl transferase inhibitor | |||
| 0.033 | 0.027 | 0.035 | Phosphoglycerate kinase inhibitor | 0.035 0.024 CID_3651 | CID_3651 | |
| 0.054 | 0.049 | 0.054 | Pregnane X receptor antagonist | 0.053 0.051 CID_3651 | ||
| 0.025 | 0.02 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.015 | 0.011 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 CID_3651 | ||
| 0.034 | 0.03 | 0.034 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.074 | 0.069 | 0.074 | Neuropeptide Y antagonist | |||
| 0.037 | 0.032 | 0.037 | Integrin antagonist | |||
| 0.022 | 0.017 | 0.032 | Beta 1 adrenoreceptor agonist | 0.032 0.007 CID_3651 | CID_3651 | |
| 0.035 | 0.031 | 0.035 | Glutamate (mGluR group II) antagonist | |||
| 0.02 | 0.016 | 0.02 | Human T-cell leukemia virus type I protease inhibitor | |||
| 0.018 | 0.014 | 0.018 | Complement factor D inhibitor | |||
| 0.036 | 0.033 | 0.036 | Integrin alpha1beta1 antagonist | |||
| 0.018 | 0.016 | 0.018 | Somatostatin 3 antagonist | |||
| 0.034 | 0.031 | 0.034 | Integrin alpha2 antagonist | |||
| 0.037 | 0.035 | 0.037 | Thymidine kinase inhibitor | |||
| 0.025 | 0.022 | 0.025 | Melanocortin 3 antagonist | |||
| 0.035 | 0.033 | 0.035 | Vascular adhesion protein 1 inhibitor | |||
| 0.027 | 0.025 | 0.036 | Estrogen-related receptor gamma antagonist | 0.036 0.008 CID_3651 | CID_3651 | |
| 0.057 | 0.055 | 0.057 | 5 Hydroxytryptamine 3 agonist | |||
| 0.017 | 0.015 | 0.017 | Cyclin T1 inhibitor | |||
| 0.017 | 0.016 | 0.017 | Bombesin 3 receptor agonist | |||
| 0.028 | 0.026 | 0.028 | Somatostatin agonist | |||
| 0.029 | 0.027 | 0.029 | Trypsin I inhibitor | |||
| 0.01 | 0.009 | 0.01 | Melatonin 5 antagonist | |||
| 0.012 | 0.011 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.123 | 0.122 | 0.123 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.123 | 0.122 | 0.123 | Pregnane X receptor agonist | |||
| 0.06 | 0.06 | 0.071 | Carbonic anhydrase VA inhibitor | 0.071 0.045 CID_3651 | CID_3651 | |
| 0.064 | 0.064 | 0.107 | Carbonic anhydrase XIII inhibitor | 0.107 0.035 CID_3651 | CID_3651 | |
| 0.046 | 0.046 | 0.051 | CD45 antagonist | 0.051 0.033 CID_3651 | CID_3651 | |
| 0.116 | 0.117 | 0.138 | Insulin secretagoues | 0.138 0.087 CID_3651 | CID_3651 | |
| 0.054 | 0.055 | 0.07 | Selectin antagonist | 0.07 0.042 CID_3651 | CID_3651 | |
| 0.013 | 0.014 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CID_3651 | CID_3651 | |
| 0.014 | 0.016 | 0.016 | KiSS-1 receptor antagonist | 0.016 0.013 CID_3651 | CID_3651 | |
| 0.03 | 0.034 | 0.042 | Nicotinic acid receptor agonist | 0.042 0.019 CID_3651 | CID_3651 | |
| 0.055 | 0.061 | 0.068 | Carbonic anhydrase V inhibitor | 0.068 0.044 CID_3651 | CID_3651 | |
| 0.049 | 0.057 | 0.058 | Acetylcholine M3 receptor antagonist | 0.058 0.044 CID_3651 | CID_3651 | |
| 0.051 | 0.061 | 0.053 | Leukotriene C antagonist | 0.053 0.049 CID_3651 | CID_3651 | |
| 0.047 | 0.058 | 0.052 | Dihydroorotate oxidase inhibitor | 0.052 0.046 CID_3651 | CID_3651 | |
| 0.031 | 0.042 | 0.039 | Dihydropteroate synthase inhibitor | 0.039 0.028 CID_3651 | CID_3651 | |
| 0.033 | 0.045 | 0.052 | Opioid kappa receptor agonist | 0.052 0.023 CID_3651 | CID_3651 | |
| 0.012 | 0.025 | 0.016 | Thyroid hormone alpha agonist | 0.016 0.012 CID_3651 | CID_3651 | |
| 0.037 | 0.054 | 0.053 | Carbonic anhydrase XIV inhibitor | 0.053 0.03 CID_3651 | CID_3651 | |
| 0.004 | 0.022 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 CID_3651 | CID_3651 | |
| 0.095 | 0.113 | 0.153 | Bone formation stimulant | 0.153 0.056 CID_3651 | CID_3651 | |
| 0.043 | 0.062 | 0.051 | Leukotriene B4 antagonist | 0.051 0.041 CID_3651 | CID_3651 | |
| 0.039 | 0.061 | 0.078 | Maillard reaction inhibitor | 0.078 0.026 CID_3651 | CID_3651 | |
| 0.11 | 0.135 | 0.132 | Hexokinase inhibitor | 0.132 0.102 CID_3651 | CID_3651 | |
| 0.047 | 0.073 | 0.07 | Heat shock protein 90 beta antagonist | 0.07 0.028 CID_3651 | CID_3651 | |
| 0.039 | 0.071 | 0.067 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.067 0.024 CID_3651 | CID_3651 | |
| 0.042 | 0.074 | 0.057 | Androgen agonist | 0.057 0.046 CID_3651 | CID_3651 | |
| 0.041 | 0.074 | 0.052 | Factor III inhibitor | 0.052 0.03 CID_3651 | CID_3651 | |
| 0.063 | 0.098 | 0.101 | Potassium channel (Ca-activated) activator | 0.101 0.054 CID_3651 | CID_3651 | |
| 0.091 | 0.134 | 0.12 | Alkaline phosphatase inhibitor | 0.12 0.086 CID_3651 | CID_3651 | |
| 0.086 | 0.141 | 0.113 | NADPH oxidase inhibitor | 0.113 0.092 CID_3651 | CID_3651 | |
| 0.044 | 0.104 | 0.067 | Neuraminidase (influenza) inhibitor | 0.067 0.04 CID_3651 | CID_3651 | |
| 0.034 | 0.105 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.048 CID_3651 | CID_3651 | |
| 0.03 | 0.102 | 0.059 | Neuraminidase inhibitor | 0.059 0.045 CID_3651 | CID_3651 | |
| 0.043 | 0.114 | 0.072 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.072 0.058 CID_3651 | CID_3651 | |
| 0.1 | 0.173 | 0.147 | Heat shock protein 90 alpha antagonist | 0.147 0.09 CID_3651 | CID_3651 | |
| 0.066 | 0.141 | 0.097 | Xanthine oxidase inhibitor | 0.097 0.063 CID_3651 | CID_3651 | |
| 0.071 | 0.146 | 0.113 | Toll-Like receptor 4 antagonist | 0.113 0.051 CID_3651 | CID_3651 | |
| 0.124 | 0.2 | 0.178 | Vasodilator | 0.178 0.123 CID_3651 | CID_3651 | |
| 0.048 | 0.125 | 0.091 | Macrophage migration inhibitory factor inhibitor | 0.091 0.04 CID_3651 | CID_3651 | |
| 0.041 | 0.117 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.034 CID_3651 | CID_3651 | |
| 0.198 | 0.279 | 0.279 | Cyclophilin D inhibitor | 0.279 0.182 CID_3651 | CID_3651 | |
| 0.197 | 0.279 | 0.343 | Apoptosis agonist | 0.343 0.143 CID_3651 | CID_3651 | |
| 0.089 | 0.176 | 0.25 | Amyloid beta aggregation inhibitor | 0.25 0.058 CID_3651 | CID_3651 | |
| 0.102 | 0.19 | 0.17 | Hepatoprotectant | 0.17 0.09 CID_3651 | CID_3651 | |
| 0.062 | 0.155 | 0.126 | DNA polymerase I inhibitor | 0.126 0.064 CID_3651 | CID_3651 | |
| 0.082 | 0.184 | 0.145 | Protein-tyrosine phosphatase inhibitor | 0.145 0.084 CID_3651 | CID_3651 | |
| 0.155 | 0.259 | 0.313 | Sodium/bile acid cotransporter inhibitor | 0.313 0.068 CID_3651 | CID_3651 | |
| 0.091 | 0.196 | 0.134 | Platelet adhesion inhibitor | 0.134 0.125 CID_3651 | CID_3651 | |
| 0.051 | 0.159 | 0.077 | Estrogen receptor alpha antagonist | 0.077 0.053 CID_3651 | CID_3651 | |
| 0.132 | 0.239 | 0.22 | 12-Lipoxygenase inhibitor | 0.22 0.13 CID_3651 | CID_3651 | |
| 0.104 | 0.219 | 0.327 | Free radical scavenger | 0.327 0.045 CID_3651 | CID_3651 | |
| 0.084 | 0.202 | 0.131 | Heat shock protein 90 antagonist | 0.131 0.096 CID_3651 | CID_3651 | |
| 0.108 | 0.268 | 0.192 | Lipoxygenase inhibitor | 0.192 0.149 CID_3651 | CID_3651 | |
| 0.045 | 0.211 | 0.124 | Chelator | 0.124 0.05 CID_3651 | CID_3651 | |
| 0.095 | 0.264 | 0.298 | Antioxidant | 0.298 0.062 CID_3651 | CID_3651 | |
| 0.048 | 0.239 | 0.183 | Lipid peroxidase inhibitor | 0.183 0.049 CID_3651 | CID_3651 | |
| 0.131 | 0.334 | 0.229 | Caspase 3 stimulant | 0.229 0.132 CID_3651 | CID_3651 | |
| 0.118 | 0.323 | 0.21 | 15-Lipoxygenase inhibitor | 0.21 0.202 CID_3651 | CID_3651 | |
| 0.052 | 0.292 | 0.087 | Interleukin 12 antagonist | 0.087 0.078 CID_3651 | CID_3651 | |
| 0.058 | 0.297 | 0.137 | Farnesoid X receptor antagonist | 0.137 0.07 CID_3651 | CID_3651 | |
| 0.053 | 0.305 | 0.144 | Interleukin 4 antagonist | 0.144 0.056 CID_3651 | CID_3651 | |
| 0.059 | 0.32 | 0.14 | Nitric oxide antagonist | 0.14 0.105 CID_3651 | CID_3651 | |
| 0.081 | 0.355 | 0.134 | MAP kinase kinase 4 inhibitor | 0.134 0.103 CID_3651 | CID_3651 | |
| 0.003 | 0.378 | 0.038 | Estrogen receptor alpha agonist | 0.038 0.022 CID_3651 | CID_3651 | |
| 0.01 | 0.404 | 0.036 | Estrogen-related receptor beta antagonist | 0.036 0.015 CID_3651 | CID_3651 | |
| 0.003 | 0.437 | 0.03 | Estrogen receptor beta agonist | 0.03 0.023 CID_3651 | CID_3651 | |
| 0.016 | 0.453 | 0.099 | M18 aspartyl aminopeptidase inhibitor | 0.099 0.093 CID_3651 | CID_3651 | |
| 0.004 | 0.444 | 0.055 | Estrogen agonist | 0.055 0.033 CID_3651 | CID_3651 | |
| 0.012 | 0.59 | 0.13 | Estrogen receptor beta antagonist | 0.13 0.023 CID_3651 | CID_3651 | |
| 0.018 | 0.606 | 0.142 | Estrogen antagonist | 0.142 0.027 CID_3651 | CID_3651 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |